Pfizer – PFE – 297th consecutive quarterly dividend paid


Pfizer Inc. (NYSE: PFE) Declares First-Quarter 2013 Dividend

  • Board of Directors approves increase in quarterly cash dividend to $0.24 per share

The board of directors of Pfizer Inc. (PFE) declared a 24-cent first-quarter 2013 dividend on the company’s common stock, payable March 5, 2013, to shareholders of record at the close of business on February 1, 2013. Pfizer increased the dividend by approximately 9 percent, to 24 cents from 22 cents per share.

The first-quarter 2013 cash dividend will be the 297th consecutive quarterly dividend paid by Pfizer.

“The dividend increase is a testament to our continued commitment to returning capital to shareholders and demonstrates our continued confidence in the business,” stated Ian Read, Pfizer chairman and chief executive officer. “We remain focused on total return to shareholders, of which the dividend is a key component.”

About Pfizer Inc. – PFE

Pfizer Inc. (PFE) is a research-based, global biopharmaceutical company. PFE manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health and Consumer Healthcare, and Nutrition.

The Company’s diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Its Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. On August 1, 2011, it completed the sale of its Capsugel business. In October 2011, it acquired Icagen, Inc. In December 2011, it acquired the consumer healthcare business of Ferrosan Holding A/S. In December 2011, it acquired Excaliard Pharmaceuticals, Inc. In November 2012, the Company acquired NextWave Pharmaceuticals, Inc.

More Posts by this author


edliston
Post Written By: Ed Liston
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing in his yacht.

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...